Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Comment by Interpolation1on Jul 13, 2016 9:42am
54 Views
Post# 25047704

RE:Here is the news release.

RE:Here is the news release.I actually expect a dip today in SP ... maybe if only in the morning and I have my BUY Order placed.  Due to lack of coverage in this sector, NEWS usually takes a day or two ....

DDivanovich wrote:

Dr. Avtar Dhillon reports

HEALTH CANADA AUTHORIZES EMERALD HEALTH TO SELL CANNABIS OIL

Emerald Health Therapeutics Inc.'s wholly owned subsidiary, Emerald Health Botanicals Inc., has received a supplemental licence from Health Canada authorizing Botanicals to sell cannabis oils. Botanicals expects to launch its suite of cannabis oil products shortly, which will include THCA (tetrahydrocannabinolic acid) oil, THC oil, as well as oils containing both THC and CBD.

From its research program funded by National Research Council of Canada-IRAP grants, the Botanicals team has characterized several new strains from its diverse pool of cannabis seeds. Strains with exceptionally high CBD levels will allow Botanicals to produce CBD oils with unique compositions of cannabinoids through blending.

"As life science professionals we are excited about being able to offer our clients medical cannabis in a form that can be precisely dosed and ingested. Our patients will now be able to access the benefits of medicinal cannabis through a wider range of routes of administration," stated Dr. Avtar Dhillon, chairman of Therapeutics.



Bullboard Posts